London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has become a Founding Supporter of the British Neuroscience Association’s (BNA) inaugural Scholars programme, which aims to support students from under-represented ethnic groups to thrive in neuroscience…


Previous articleFilament Health Corp. Announces Approval for Listing on the Neo Exchange
Next articleNova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board